Sonnet announces release of corporate update video

Princeton, n.j., april 01, 2025 (globe newswire) -- sonnet biotherapeutics holdings, inc. (nasdaq:sonn) (the "company" or "sonnet"), a clinical-stage company developing immunotherapeutic drugs targeted to the tumor microenvironment (tme), today announced the release of a corporate update video. access the video here.

SONN Ratings Summary

SONN Quant Ranking